Please find attached the second report from MSNZ regarding Ocrelizumab and our Advocacy around this new disease modifying treatment. All the information is also available the website here https://www.msnz.org.nz/SSLPage.aspx?pid=627 Ocrelizumab is not yet registered with Medsafe or funded by PHARMAC in NZ but applications are underway. Actively Advocating – Ocelizumab – July 2017